His academic salary is provided by funds from the University of Southern California and grants from the NIH and American Cancer Society. Each year he typically receives honoraria for his services on behalf of the U.S. federal government (e.g., grant reviews) and from academic medical centers (e.g., speaking engagements, research consulting). Elsevier, the owner and publisher of Drug and Alcohol Dependence, provides an honorarium to Dr. Leventhal for his efforts as an Associate Editor of the journal. Dr. Leventhal currently has no investments in pharmaceutical, tobacco, or alcohol beverage or other firms with entrepreneurial activities pertinent to his service as an Associate Editor aside from possible inclusion in mutual funds over which he has no control as an individual investor. (Updated July, 2017)